Reduced FBXO22 skews human trophoblast fate equilibrium toward syncytialization via polyubiquitinating the CoREST complex. [PDF]
Li H +14 more
europepmc +1 more source
Correction: Carrier-free supramolecular nanoassemblies of pure LSD1 inhibitor for effective anti-tumor therapy. [PDF]
Li B, Zhang X, Li J.
europepmc +1 more source
Therapeutic advances in acute myeloid leukemia: from LSD1 blockade to PROTAC-based strategies. [PDF]
Khan SA, Qamar MA, Feroze MT.
europepmc +1 more source
Metabolic oxidoreductases: central regulators of the epigenetic landscapes in stemness. [PDF]
Lee HT, Roe JS, Youn HD.
europepmc +1 more source
ARID1A deficiency-driven reprogramming of polyamine metabolism promotes endometrial cancer malignancy and immune escape. [PDF]
Tao H +7 more
europepmc +1 more source
Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibition. [PDF]
Saifullah MK +9 more
europepmc +1 more source
Evaluation of [<sup>18</sup>F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1A (LSD1), in non-human primates. [PDF]
Petibon Y +8 more
europepmc +1 more source
Metabolic reprogramming-a breakthrough point in overcoming resistance to BRAF mutant melanoma targeted therapy (Review). [PDF]
Zhao X, Chen F, Li H.
europepmc +1 more source
ORY1001 enhances anti-tumor immunity via CXCL10-mediated macrophage modulation in EBV-positive DLBCL. [PDF]
Kim JH, Cho HJ, Yoon SE, Kim WS.
europepmc +1 more source

